• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球女性持续性生殖器人乳头瘤病毒感染模式:文献回顾和荟萃分析。

Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.

机构信息

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

出版信息

Int J Cancer. 2013 Sep 15;133(6):1271-85. doi: 10.1002/ijc.27828. Epub 2012 Oct 11.

DOI:10.1002/ijc.27828
PMID:22961444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3707974/
Abstract

Persistent high-risk human papillomavirus (HR-HPV) infection is the strongest risk factor for high-grade cervical precancer. We performed a systematic review and meta-analysis of HPV persistence patterns worldwide. Medline and ISI Web of Science were searched through January 1, 2010 for articles estimating HPV persistence or duration of detection. Descriptive and meta-regression techniques were used to summarize variability and the influence of study definitions and characteristics on duration and persistence of cervical HPV infections in women. Among 86 studies providing data on over 100,000 women, 73% defined persistence as HPV positivity at a minimum of two time points. Persistence varied notably across studies and was largely mediated by study region and HPV type, with HPV-16, 31, 33 and 52 being most persistent. Weighted median duration of any-HPV detection was 9.8 months. HR-HPV (9.3 months) persisted longer than low-risk HPV (8.4 months), and HPV-16 (12.4 months) persisted longer than HPV-18 (9.8 months). Among populations of HPV-positive women with normal cytology, the median duration of any-HPV detection was 11.5 and HR-HPV detection was 10.9 months. In conclusion, we estimated that approximately half of HPV infections persist past 6 to 12 months. Repeat HPV testing at 12-month intervals could identify women at increased risk of high-grade cervical precancer due to persistent HPV infections.

摘要

持续存在高危型人乳头瘤病毒(HR-HPV)感染是宫颈癌前病变的最强危险因素。我们对全球范围内 HPV 持续性模式进行了系统评价和荟萃分析。检索了 Medline 和 ISI Web of Science 数据库,以获取截至 2010 年 1 月 1 日评估 HPV 持续性或检测持续时间的文章。采用描述性和荟萃回归技术来总结变异性以及研究定义和特征对女性宫颈 HPV 感染持续性和持续时间的影响。在提供超过 10 万名女性数据的 86 项研究中,73%的研究将持续性定义为至少两个时间点的 HPV 阳性。研究间的持续性差异显著,主要由研究区域和 HPV 型别介导,HPV-16、31、33 和 52 最为持续。任何 HPV 检测的加权中位数持续时间为 9.8 个月。HR-HPV(9.3 个月)的持续性长于低危型 HPV(8.4 个月),HPV-16(12.4 个月)的持续性长于 HPV-18(9.8 个月)。在细胞学正常的 HPV 阳性女性人群中,任何 HPV 检测的中位持续时间为 11.5 个月,HR-HPV 检测的中位持续时间为 10.9 个月。总之,我们估计大约有一半的 HPV 感染持续存在超过 6-12 个月。间隔 12 个月重复 HPV 检测可识别出因持续性 HPV 感染而处于宫颈癌前病变高风险的女性。

相似文献

1
Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.全球女性持续性生殖器人乳头瘤病毒感染模式:文献回顾和荟萃分析。
Int J Cancer. 2013 Sep 15;133(6):1271-85. doi: 10.1002/ijc.27828. Epub 2012 Oct 11.
2
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.接种人乳头瘤病毒预防性疫苗以预防宫颈癌及其癌前病变。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
3
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.人乳头瘤病毒基因分型检测在日本女性自行采集的尿液和阴道样本癌症筛查中的效用
Gynecol Obstet Invest. 2025;90(2):143-152. doi: 10.1159/000541641. Epub 2024 Oct 7.
4
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.全球和地区男性人群生殖器人乳头瘤病毒感染率的估计:系统评价和荟萃分析。
Lancet Glob Health. 2023 Sep;11(9):e1345-e1362. doi: 10.1016/S2214-109X(23)00305-4.
5
Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.在未进行人乳头瘤病毒(HPV)检测的情况下,对于轻度宫颈细胞学异常,立即转诊至阴道镜检查与细胞学监测的比较
Cochrane Database Syst Rev. 2017 Jan 26;1(1):CD009836. doi: 10.1002/14651858.CD009836.pub2.
6
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].[卫生技术评估报告。液基细胞学在宫颈癌前病变筛查中的应用]
Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 2):e1-e33.
7
Cytology versus HPV testing for cervical cancer screening in the general population.普通人群宫颈癌筛查中细胞学检查与HPV检测的比较
Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2.
8
Prevalence of human papillomavirus in women attending cervical screening in the UK and Ireland: new data from northern Ireland and a systematic review and meta-analysis.英国和爱尔兰接受宫颈癌筛查女性的人乳头瘤病毒流行率:来自北爱尔兰的新数据及系统评价和荟萃分析。
J Med Virol. 2013 Feb;85(2):295-308. doi: 10.1002/jmv.23459. Epub 2012 Nov 14.
9
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.细胞学正常女性宫颈人乳头瘤病毒DNA的全球流行率及基因型分布:一项荟萃分析
Lancet Infect Dis. 2007 Jul;7(7):453-9. doi: 10.1016/S1473-3099(07)70158-5.
10
The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature.非宫颈人乳头瘤病毒感染的发病率、清除率及持续情况:文献系统综述
BMC Infect Dis. 2016 Jun 14;16:293. doi: 10.1186/s12879-016-1633-9.

引用本文的文献

1
Medicinal Mushrooms, Probiotics and Combination of Natural Compounds in the Management of HPV: A Comparative Look at Viral Clearance and Lesion Resolution.药用蘑菇、益生菌及天然化合物组合用于人乳头瘤病毒管理:病毒清除与病变消退的比较研究
Viruses. 2025 Jul 2;17(7):942. doi: 10.3390/v17070942.
2
Adverse events following 9-valent human papillomavirus vaccine (GARDASIL® 9) reported to the Vaccine Adverse Event Reporting System (VAERS), 2015-2024.2015年至2024年向疫苗不良事件报告系统(VAERS)报告的9价人乳头瘤病毒疫苗(佳达修9®)接种后的不良事件。
Hum Vaccin Immunother. 2025 Dec;21(1):2530831. doi: 10.1080/21645515.2025.2530831. Epub 2025 Jul 15.
3

本文引用的文献

1
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.美国癌症协会、美国阴道镜和宫颈病理学会以及美国临床病理学会宫颈癌预防和早期检测筛查指南。
Am J Clin Pathol. 2012 Apr;137(4):516-42. doi: 10.1309/AJCPTGD94EVRSJCG.
2
A global review of age-specific and overall prevalence of cervical lesions.全球范围内特定年龄段和总体宫颈病变的流行情况综述。
Int J Gynecol Cancer. 2010 Oct;20(7):1244-9. doi: 10.1111/igc.0b013e3181f16c5f.
3
Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression.
Ischemic Heart Disease, Hematological Malignancies, and Infectious Diseases as Risk Factors for Cervical Cancer: A Study Based on Korean National Health Insurance Data.
缺血性心脏病、血液系统恶性肿瘤和传染病作为宫颈癌的危险因素:一项基于韩国国民健康保险数据的研究。
J Clin Med. 2025 Jun 16;14(12):4282. doi: 10.3390/jcm14124282.
4
A Prospective, Non-interventional Observational Study to Assess the Efficacy, Safety, and Tolerability of the Casein Hydrolysate-Based Food Supplement in High-Risk Human Papillomavirus-Positive Women.一项前瞻性、非干预性观察性研究,旨在评估基于酪蛋白水解物的食品补充剂在高危人乳头瘤病毒阳性女性中的疗效、安全性和耐受性。
Cureus. 2025 Mar 7;17(3):e80201. doi: 10.7759/cureus.80201. eCollection 2025 Mar.
5
Detecting epithelial-mesenchymal transition signaling molecules in cervical epithelial cells aids in the early diagnosis of cervical lesions.检测宫颈上皮细胞中的上皮-间质转化信号分子有助于宫颈病变的早期诊断。
BMC Cancer. 2024 Dec 27;24(1):1582. doi: 10.1186/s12885-024-13355-7.
6
Global pattern of persistent human papillomavirus infection in female genital tract: An update system review and meta-analysis.女性生殖道持续性人乳头瘤病毒感染的全球模式:一项更新的系统评价和荟萃分析。
iScience. 2024 Sep 19;27(10):110991. doi: 10.1016/j.isci.2024.110991. eCollection 2024 Oct 18.
7
A real-world, cross-sectional, and longitudinal study on high-risk human papillomavirus genotype distribution in 31,942 women in Dongguan, China.中国东莞 31942 例女性高危型人乳头瘤病毒基因型的横断面和纵向研究。
Front Public Health. 2024 Aug 1;12:1409030. doi: 10.3389/fpubh.2024.1409030. eCollection 2024.
8
Human Papillomavirus Carcinogenicity and the Need of New Perspectives: Thoughts from a Retrospective Analysis on Human Papillomavirus Outcomes Conducted at the Hospital University of Bari, Apulia, Italy, between 2011 and 2022.人乳头瘤病毒致癌性及新视角的必要性:来自2011年至2022年在意大利普利亚大区巴里大学医院进行的一项关于人乳头瘤病毒结果的回顾性分析的思考
Diagnostics (Basel). 2024 May 6;14(9):968. doi: 10.3390/diagnostics14090968.
9
Utility of expression of 4-hydroxynonenal tested by immunohistochemistry for cervical cancer.免疫组织化学检测4-羟基壬烯醛表达在宫颈癌中的应用价值。
Prz Menopauzalny. 2024 Mar;23(1):6-13. doi: 10.5114/pm.2024.136356. Epub 2024 Mar 18.
10
Impact of HPV Vaccination on the Incidence of High-Grade Cervical Intraepithelial Neoplasia (CIN2+) in Women Aged 20-25 in the Northern Part of Norway: A 15-Year Study.人乳头瘤病毒(HPV)疫苗接种对挪威北部20至25岁女性高级别宫颈上皮内瘤变(CIN2+)发病率的影响:一项为期15年的研究
Vaccines (Basel). 2024 Apr 16;12(4):421. doi: 10.3390/vaccines12040421.
病毒 DNA 在上皮基底层的持续存在提示了 HPV 潜伏感染在免疫逃逸后的一种模型。
Virology. 2011 Jun 5;414(2):153-63. doi: 10.1016/j.virol.2011.03.019. Epub 2011 Apr 13.
4
Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.德国沃尔夫斯堡适应性风险 HPV 宫颈癌筛查项目——3 年多的经验。
J Clin Virol. 2009 Nov;46 Suppl 3:S5-10. doi: 10.1016/S1386-6532(09)70294-X.
5
Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.检测高危型(HR)人乳头瘤病毒(HPV)16、18 和 45 型在癌前宫颈病变中的诊断准确性的测定:初步数据。
J Clin Virol. 2009 Nov;46 Suppl 3:S11-5. doi: 10.1016/S1386-6532(09)70295-1.
6
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.人乳头瘤病毒的短期持续感染与宫颈癌前病变及癌症风险:基于人群的队列研究
BMJ. 2009 Jul 28;339:b2569. doi: 10.1136/bmj.b2569.
7
Natural history of persistent high-risk human papillomavirus infections in Korean women.韩国女性持续性高危型人乳头瘤病毒感染的自然史
Gynecol Oncol. 2009 Oct;115(1):75-80. doi: 10.1016/j.ygyno.2009.06.016. Epub 2009 Jul 19.
8
Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology.HPV 持续感染的预测因素:细胞学检查结果为不明确意义的非典型鳞状细胞或轻度异常的女性。
Int J Cancer. 2010 Feb 1;126(3):684-91. doi: 10.1002/ijc.24752.
9
Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women.一组哥伦比亚女性中HPV感染的持续情况及高级别宫颈上皮内瘤变的风险
Br J Cancer. 2009 Apr 7;100(7):1184-90. doi: 10.1038/sj.bjc.6604972. Epub 2009 Mar 17.
10
The Mexican Cervical Cancer Screening Trial: self-sampling for human papillomavirus with unaided visual inspection as a secondary screen.墨西哥宫颈癌筛查试验:人乳头瘤病毒自检,辅以肉眼检查作为二级筛查。
Int J Gynecol Cancer. 2009 Jan;19(1):27-32. doi: 10.1111/IGC.0b013e318197f479.